chr1-54787786-T-C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001114108.2(TTC22):c.664A>G(p.Lys222Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000434 in 1,613,066 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001114108.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTC22 | NM_001114108.2 | c.664A>G | p.Lys222Glu | missense_variant | Exon 3 of 7 | ENST00000371276.9 | NP_001107580.1 | |
TTC22 | NM_017904.4 | c.664A>G | p.Lys222Glu | missense_variant | Exon 3 of 6 | NP_060374.2 | ||
TTC22 | XM_011541671.3 | c.664A>G | p.Lys222Glu | missense_variant | Exon 3 of 6 | XP_011539973.1 | ||
TTC22 | XM_017001582.2 | c.91A>G | p.Lys31Glu | missense_variant | Exon 3 of 7 | XP_016857071.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152156Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000602 AC: 15AN: 248970 AF XY: 0.0000817 show subpopulations
GnomAD4 exome AF: 0.0000466 AC: 68AN: 1460792Hom.: 1 Cov.: 32 AF XY: 0.0000523 AC XY: 38AN XY: 726606 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152274Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74456 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.664A>G (p.K222E) alteration is located in exon 3 (coding exon 3) of the TTC22 gene. This alteration results from a A to G substitution at nucleotide position 664, causing the lysine (K) at amino acid position 222 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at